资讯
Percutaneous transluminal angioplasty (PCTA) is a surgical procedure to treat heart disease. It involves inserting a small balloon into the arteries to manage blockages or restore blood flow.
The global percutaneous transluminal angioplasty (PTA) balloons market was valued at approximately US$ 2.1 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 5.4%, ...
Standard percutaneous transluminal angioplasty is the current recommended treatment for dysfunctional hemodialysis fistulas, yet long-term outcomes of this treatment are poor. Drug-coated balloons ...
Atherosclerotic disease in the femoral and popliteal (femoropopliteal) arteries compromises perfusion to the legs and feet. Although treatment with percutaneous transluminal angioplasty is ...
TCT 317: Twelve-Month Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System Following Percutaneous Transluminal Angioplasty of Below-the-Knee Arteries in Patients With ...
Teleflex announced its percutaneous transluminal coronary angioplasty perfusion balloon catheter has received FDA 510(k) clearance for balloon dilatation of coronary artery or coronary bypass ...
1.6 NICE encourages further research into vaginal transluminal endoscopic hysterectomy and adnexal surgery for benign gynaecological conditions and may update the guidance on publication of further ...
Compared with other medications, semaglutide was associated with a 24% lower risk for peripheral percutaneous transluminal angioplasty (HR, 0.76; P = .045) and a 50% lower risk for lower extremity ...
Current evidence on the safety of endoscopic transluminal pancreatic necrosectomy shows that there are serious but well‑recognised complications. Evidence on efficacy is adequate to support the use of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果